Antibodies against cancer antigen TMEFF2 and uses thereof
US7288248B2 · kind B2 · utility
18Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2003 |
| Grant date | Oct 30, 2007 |
| Priority date | — |
| Expiry date | Sep 1, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.